Market revenue in 2023 | USD 43.4 million |
Market revenue in 2030 | USD 122.3 million |
Growth rate | 16% (CAGR from 2023 to 2030) |
Largest segment | Product |
Fastest growing segment | Service |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Product, Service |
Key market players worldwide | AstraZeneca PLC, Caribou Biosciences Inc Ordinary Shares, Cellectis SA, CRISPR Therapeutics AG, Editas Medicine Inc, Roche Holding AG, PerkinElmer, Genscript Biotech Corp Class H, Danaher Corp, Intellia Therapeutics Inc, Lonza Group Ltd, Merck KGaA, Takara Bio Inc, Thermo Fisher Scientific Inc, Cibus Inc Ordinary Shares - Class A, Beam Therapeutics Inc, Vertex Pharmaceuticals Inc, Addgene, EGenesis, Synthego, Mammoth Biosciences, Inscripta, PLANTEDIT, Hera Biotech, Origene Technologies, Recombinetics |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to crispr and cas genes market will help companies and investors design strategic landscapes.
Product was the largest segment with a revenue share of 78.57% in 2023. Horizon Databook has segmented the Brazil crispr and cas genes market based on product, service covering the revenue growth of each sub-segment from 2018 to 2030.
Brazil is expected to adopt gene modification tools primarily for the production of GM crops. The country was reported to have the second-largest area under cultivation for GM crops. In June 2018, the country expanded its area dedicated to cultivating GM crops by 1.1 million hectares and yielded food products such as soy and corn.
Biotech crops, including cotton, soybean, and corn, represent about 94% of such crops in Brazil. The country is expected to witness continuous growth and developments in GM crops. This can increase the demand for CRISPR technologies in the agriculture industry, as Brazil continues to show a high preference for GM crops.
Horizon Databook provides a detailed overview of country-level data and insights on the Brazil crispr and cas genes market , including forecasts for subscribers. This country databook contains high-level insights into Brazil crispr and cas genes market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account